logo

HDFC Pharma and Healthcare Reg IDCW-R

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

HDFC Pharma and Healthcare Reg IDCW-R

as of 23 Apr 2026, 09:05 AM

Scheme Asset Size₹2030.81 Cr
Expense Ratio2.09%
Cash Holding1.75604%
Fund TypeOpen-End
PlanDividend
BenchmarkBSE Healthcare TR INR
Launch Date2023-10-04
Exit LoadExit load of 1.00% for investments if redeemed within 30 Days

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months -0.55%
In the last 3 months 1.12%
In the last 6 months 1.49%
In the last 1 Years 16.49%
In the last 3 Years 0.00%
In the last 5 Years 0.00%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE9.81%
Divi's Laboratories LtdHealthcareE8.38%
Glenmark Pharmaceuticals LtdHealthcareE6.62%
Lupin LtdHealthcareE6.44%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE6.36%
Alkem Laboratories LtdHealthcareE6.21%
Aster DM Healthcare Ltd Ordinary SharesHealthcareE5.42%
Ipca Laboratories LtdHealthcareE4.80%
Anthem Biosciences LtdHealthcareE4.46%
Fortis Healthcare LtdHealthcareE4.02%
Krishna Institute of Medical Sciences LtdHealthcareE3.61%
Acutaas Chemicals LtdBasic MaterialsE3.60%
Laurus Labs LtdHealthcareE2.91%
Metropolis Healthcare LtdHealthcareE2.53%
Torrent Pharmaceuticals LtdHealthcareE2.34%
Vijaya Diagnostic Centre LtdHealthcareE2.30%
Eris Lifesciences Ltd Registered ShsHealthcareE2.28%
Sai Life Sciences LtdHealthcareE2.09%
Global Health LtdHealthcareE1.84%
Wockhardt LtdHealthcareE1.73%
Shilpa Medicare LtdHealthcareE1.68%
Dr. Lal PathLabs LtdHealthcareE1.63%
Thyrocare Technologies LtdHealthcareE1.39%
Jubilant Pharmova LtdHealthcareE1.35%
Rubicon Research LtdHealthcareE1.22%
Gland Pharma LtdHealthcareE1.12%
Bajaj Healthcare LtdHealthcareE0.92%
Laxmi Dental LtdHealthcareE0.61%
Corona Remedies LtdHealthcareE0.55%
Treps - Tri-Party Repo-CR1.88%
Net Current Assets-C0.12%

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

98.24%

Cash

1.76%

Equity sector allocation

Loading chart…

Basic Materials

3.6%

Healthcare

94.64%

Others

1.76%

Fund House Contact Details

Websitewww.hdfcfund.com
Phone+91 22 66316333
Logo
HDFC Asset Management Co Ltd

Asset Management Company

About HDFC Pharma and Healthcare Reg IDCW-R

Investment Objective of the Scheme

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Key Features of The Fund

5-year return

-

Fund Manager

Dhruv Muchhal

Risk Profile

Very High Risk

Expense Ratio

2.09%

Fund Size

₹2030.81 Cr

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy